1. Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma. (11th October 2016) Authors: Fiteni, Frédéric; Paget‐Bailly, Sophie; Messager, Mathieu; N'Guyen, Thierry; Lakkis, Zaher; Mathieu, Pierre; Lamfichekh, Najib; Picard, Alain; Benzidane, Bilell; Cléau, Denis; Bonnetain, Franck; Borg, Christophe; Mariette, Christophe; Kim, Stefano Journal: Cancer medicine Issue: Volume 5:Number 11(2016:Nov.) Page Start: 3085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial. Issue 1 (December 2016) Authors: Messager, Mathieu; Mirabel, Xavier; Tresch, Emmanuelle; Paumier, Amaury; Vendrely, Véronique; Dahan, Laetitia; Glehen, Olivier; Vasseur, Frederique; Lacornerie, Thomas; Piessen, Guillaume; El Hajbi, Farid; Robb, William; Clisant, Stéphanie; Kramar, Andrew; Mariette, Christophe; Adenis, Antoine Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗